Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis

  • Moneeb Sefeldawla Mustafa Internal Medicine Department, St. Luke General Hospital, Kilkenny, Ireland
  • Megan Marshal Internal Medicine Department, St. Luke General Hospital, Kilkenny, Ireland
  • Emer Ahern Internal Medicine Department, St. Luke General Hospital, Kilkenny, Ireland
  • Paul Crowley Internal Medicine Department, St. Luke General Hospital, Kilkenny, Ireland

Abstract

Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness.
The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis. More generally, the disease can result in fluctuant weakness of skeletal muscle, predominantly affecting ocular, bulbar and respiratory muscles. Autoimmunity in this instance is mediated by IgG anti-acetylcholine receptor antibodies that results in an impaired structure of postsynaptic neurotransmission. Approximately 15% of patients with myasthenia gravis present with bulbar symptoms, of which isolated bulbar symptoms are seen only on occasion. As with our patient, this presentation is most commonly seen in men with late-onset myasthenia gravis.
We present a case of an 83-year-old male who presented with a 1 year history of dysphagia for solids and fatigable dysarthria. Following a diagnosis of myasthenia gravis, he was initiated on corticosteroid treatment. He later descended into myasthenic crisis, requiring invasive ventilation measures due to a failure of both non-invasive ventilation and intravenous immunoglobulin G (IVIG) to achieve therapeutic goals.

References

  • Wendell L, Levine J. Myasthenic crisis. Neurohospitalist 2011;1:16-22.

  • Basiri K, Ansari B, Okhovat A. Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: how much can one rely on exaggerated deep tendon reflexes. >Adv Biomed Res 2015;4:58.

  • Montero-Odasso M. Dysphonia as first symptom of late-onset myasthenia gravis. J Gen Intern Med 2006;21:C4-C6.

  • Sanders D, Wolfe G, Narayanaswami P. Author response: International consensus guidance for management of myasthenia gravis: executive summary. Neurology 2017;88:505-506.
  • Published: 2017-12-21

    Issue: Vol 5 No 2 (view)

    Section: Articles

    How to cite:
    Mustafa, M., Marshal, M., Ahern, E., & Crowley, P. (2017). Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis. European Journal of Case Reports in Internal Medicine, 5(2). https://doi.org/https://doi.org/10.12890/2017_000785